SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement
FORT LAUDERDALE, Fla., March 12, 2024 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System. This procedure was carried out at the Narayana Hrudayalaya Institute of Cardiac Sciences in Bengaluru, India, and represents a milestone in the treatment of heart disease using the SSi Mantra Surgical Robotic System.
Related news for (SSII)
- MoBot alert highlights: NYSE: SST, NASDAQ: LUCY, NASDAQ: PCSA, NASDAQ: CTOR, NASDAQ: SSII (06/20/25 01:00 PM)
- MoBot alert highlights: NASDAQ: PCSA, NASDAQ: CTOR, NASDAQ: SSII, NASDAQ: DPRO, NYSE: GNS (06/20/25 12:00 PM)
- Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3
- SSi Mantra Expands Global Footprint: Nepal’s First Surgical Robot Set to Transform Healthcare Sector
- SS Innovations Designated “Outstanding Company” Finalist for Surgical Robotics Industry Awards 2024